MKI67 and breast carcinoma: Moreover, we also reported that miR-622 expression was inversely correlated with aggressive clinicopathological features as advanced tumour grade and high levels of Ki67, identifying the low expression level of miR-622 as a novel prognostic factor in patients with aggressive breast cancer.